These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6607336)

  • 1. Pharmacokinetics of heparin VII: Effect of pregnancy on the relationship between concentration and anticoagulant action of heparin in rats.
    Whitfield LR; Wilkenfeld C; Levy G
    J Pharm Sci; 1984 Jan; 73(1):72-4. PubMed ID: 6607336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pregnancy on the relationship between concentration and anticoagulant action of heparin.
    Whitfield LR; Lele AS; Levy G
    Clin Pharmacol Ther; 1983 Jul; 34(1):23-8. PubMed ID: 6861435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The APTT response of pregnant plasma to unfractionated heparin.
    Chunilal SD; Young E; Johnston MA; Robertson C; Naguit I; Stevens P; Galashan D; Oskamp ML; Brennan B; Ginsberg JS
    Thromb Haemost; 2002 Jan; 87(1):92-7. PubMed ID: 11848463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between concentration and anticoagulant effect of heparin in plasma of hospitalized patients: magnitude and predictability of interindividual differences.
    Whitfield LR; Schentag JJ; Levy G
    Clin Pharmacol Ther; 1982 Oct; 32(4):503-16. PubMed ID: 7116766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of heparin V: in vivo and in vitro factors affecting the relationship between concentration and anticoagulant effect of heparin in rat plasma.
    Whitfield LR; Levy G
    J Pharm Sci; 1983 Oct; 72(10):1141-6. PubMed ID: 6644559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intersubject variability in the anticoagulant response to heparin in vitro.
    Bjornsson TD; Wolfram KM
    Eur J Clin Pharmacol; 1982; 21(6):491-7. PubMed ID: 6176454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between concentration and anticoagulant effect of heparin in plasma of normal subjects: magnitude and predictability of interindividual differences.
    Whitfield LR; Levy G
    Clin Pharmacol Ther; 1980 Oct; 28(4):509-16. PubMed ID: 7408410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pregnancy and lactation on warfarin-induced changes in blood coagulation-related parameters in rats.
    Ohishi T; Kitazawa T; Suzuki S; Nakamura D; Nishihara Y; Mochizuki M
    J Toxicol Sci; 2010 Apr; 35(2):189-96. PubMed ID: 20371969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy.
    Brancazio LR; Roperti KA; Stierer R; Laifer SA
    Am J Obstet Gynecol; 1995 Oct; 173(4):1240-5. PubMed ID: 7485329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of short term diazinon exposure on blood clotting activity in the rat.
    Lox CD
    J Environ Pathol Toxicol Oncol; 1987; 7(3):67-71. PubMed ID: 3559918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenobarbital (PB)-induced changes in blood coagulationrelated parameters in pregnant rats, lactating rats and pups.
    Mochizuki M; Shimizu S; Kidokoro Y; Kamata T; Kitazawa T; Kishi D; Okazaki E; Nishihata Y; Ohishi T
    J Toxicol Sci; 2009 Dec; 34(6):603-10. PubMed ID: 19952496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of factor VIII levels on the APTT and anti-Xa activity under a therapeutic dose of heparin.
    Mitsuguro M; Okamoto A; Shironouchi Y; Sano M; Miyata S; Neki R; Araki T; Hamamoto T; Yoshimatsu J; Miyata T
    Int J Hematol; 2015 Feb; 101(2):119-25. PubMed ID: 25416968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
    Favaloro EJ; Kershaw G; Mohammed S; Lippi G
    Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of taurolidine on experimental thrombus formation.
    Kaptanoglu L; Kucuk HF; Colak E; Kurt N; Bingul SM; Akyol H; Torlak OA; Yazici F
    Eur J Pharmacol; 2008 Jan; 578(2-3):238-41. PubMed ID: 17961549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clotting activity in the rat following acute barbiturate treatment.
    Lox CD; Frederick N
    Gen Pharmacol; 1983; 14(5):529-31. PubMed ID: 6642193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of coagulation in experimental nephrotic syndrome.
    Cruz C; Juárez-Nicolás F; Tapia E; Correa-Rotter R; Pedraza-Chaverrí J
    Nephron; 1994; 68(4):489-96. PubMed ID: 7532794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term malathion ingestion and blood clotting in the rat.
    Lox CD
    J Environ Pathol Toxicol Oncol; 1985; 6(1):51-5. PubMed ID: 4067834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro modeling of the influence of FVIII activity and heparin induced prolongation of APTT.
    Mehmedagić A; Skrbo S; Softić D; Haracić M
    Bosn J Basic Med Sci; 2005 Aug; 5(3):26-9. PubMed ID: 16351577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
    Wang ZM; Li L; Li B; Guo SY
    Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of heparin on whole blood activated partial thromboplastin time using a portable, whole blood coagulation monitor.
    Despotis GJ; Hogue CW; Santoro SA; Joist JH; Barnes PW; Lappas DG
    Crit Care Med; 1995 Oct; 23(10):1674-9. PubMed ID: 7587232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.